Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 287

1.

Serenoa repens for benign prostatic hyperplasia.

Tacklind J, MacDonald R, Rutks I, Wilt TJ.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD001423. doi: 10.1002/14651858.CD001423.pub2. Review. Update in: Cochrane Database Syst Rev. 2012;12:CD001423.

2.

Serenoa repens for benign prostatic hyperplasia.

Wilt T, Ishani A, Mac Donald R.

Cochrane Database Syst Rev. 2002;(3):CD001423. Review. Update in: Cochrane Database Syst Rev. 2009;(2):CD001423.

PMID:
12137626
3.

Serenoa repens for benign prostatic hyperplasia.

Tacklind J, Macdonald R, Rutks I, Stanke JU, Wilt TJ.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD001423. doi: 10.1002/14651858.CD001423.pub3. Review.

PMID:
23235581
4.

Serenoa repens for benign prostatic hyperplasia.

Wilt T, Ishani A, Stark G, MacDonald R, Mulrow C, Lau J.

Cochrane Database Syst Rev. 2000;(2):CD001423. Review. Update in: Cochrane Database Syst Rev. 2002;(3):CD001423.

PMID:
10796790
5.

Phytotherapy for benign prostatic hyperplasia.

Wilt TJ, Ishani A, Rutks I, MacDonald R.

Public Health Nutr. 2000 Dec;3(4A):459-72.

PMID:
11276294
6.

Pygeum africanum for benign prostatic hyperplasia.

Wilt T, Ishani A, Mac Donald R, Rutks I, Stark G.

Cochrane Database Syst Rev. 2002;(1):CD001044. Review.

PMID:
11869585
7.

Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic review.

MacDonald R, Tacklind JW, Rutks I, Wilt TJ.

BJU Int. 2012 Jun;109(12):1756-61. doi: 10.1111/j.1464-410X.2012.11172.x. Epub 2012 May 2. Review.

8.

WITHDRAWN: Cernilton for benign prostatic hyperplasia.

Wilt TJ, Macdonald R, Ishani A, Rutks I, Stark G.

Cochrane Database Syst Rev. 2011 May 11;(5):CD001042. doi: 10.1002/14651858.CD001042.pub2. Review.

PMID:
21563128
9.

Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review.

Wilt TJ, Ishani A, Stark G, MacDonald R, Lau J, Mulrow C.

JAMA. 1998 Nov 11;280(18):1604-9. Erratum in: JAMA 1999 Feb 10;281(6):515.

PMID:
9820264
10.

Cernilton for benign prostatic hyperplasia.

Wilt T, Mac Donald R, Ishani A, Rutks I, Stark G.

Cochrane Database Syst Rev. 2000;(2):CD001042. Review. Update in: Cochrane Database Syst Rev. 2011;(5):CD001042.

PMID:
10796739
11.

WITHDRAWN: Tamsulosin for benign prostatic hyperplasia.

Wilt TJ, Macdonald R, Rutks I.

Cochrane Database Syst Rev. 2011 Sep 7;(9):CD002081. doi: 10.1002/14651858.CD002081.pub2. Review.

PMID:
21901681
12.

Tamsulosin for benign prostatic hyperplasia.

Wilt TJ, Mac Donald R, Rutks I.

Cochrane Database Syst Rev. 2003;(1):CD002081. Review. Update in: Cochrane Database Syst Rev. 2011;(9):CD002081.

PMID:
12535426
13.
14.

Beta-sitosterols for benign prostatic hyperplasia.

Wilt T, Ishani A, MacDonald R, Stark G, Mulrow C, Lau J.

Cochrane Database Syst Rev. 2000;(2):CD001043. Review.

PMID:
10796740
15.
16.

Finasteride for benign prostatic hyperplasia.

Tacklind J, Fink HA, Macdonald R, Rutks I, Wilt TJ.

Cochrane Database Syst Rev. 2010 Oct 6;(10):CD006015. doi: 10.1002/14651858.CD006015.pub3. Review.

PMID:
20927745
17.

Serenoa repens extract for benign prostate hyperplasia: a randomized controlled trial.

Willetts KE, Clements MS, Champion S, Ehsman S, Eden JA.

BJU Int. 2003 Aug;92(3):267-70.

18.

WITHDRAWN: Terazosin for benign prostatic hyperplasia.

Wilt TJ, Howe RW, Rutks I, Macdonald R.

Cochrane Database Syst Rev. 2011 Sep 7;(9):CD003851. doi: 10.1002/14651858.CD003851.pub2. Review.

PMID:
21901686
19.

Microwave thermotherapy for benign prostatic hyperplasia.

Hoffman RM, Monga M, Elliott SP, Macdonald R, Langsjoen J, Tacklind J, Wilt TJ.

Cochrane Database Syst Rev. 2012 Sep 12;(9):CD004135. doi: 10.1002/14651858.CD004135.pub3. Review.

PMID:
22972068
20.

Terazosin for benign prostatic hyperplasia.

Wilt TJ, Howe RW, Rutks IR, MacDonald R.

Cochrane Database Syst Rev. 2002;(4):CD003851. Review. Update in: Cochrane Database Syst Rev. 2011;(9):CD003851.

PMID:
12519611

Supplemental Content

Support Center